Sign inJoin waitlistJoin the waitlist

Momna Warraich

Internal Medicine Residency · Allegheny Health Network Medical Education Consortium

Credentials: · ·

History

Internal Medicine
Allegheny Health Network Medical Education Consortium
2026–Present
Shifa College of Medicine
2022–2026

Research

TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast-Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus…
American Journal of Hematology · 2026 · 1 citations
Evaluation and Association of Hematological and Biochemical Parameters of Untreated COVID-19 Patients on the basis of Differences in Ethnicity and Curcumin as a Possible Treatment
Endocrine · 2025 · 1 citations
Older Age, STAG2, and DNMT3A Mutations Predict Superior Posttransplant Survival in Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents
American Journal of Hematology · 2026 · First of 20 authors

Antoine Saliba
5 papers
Aref Al-Kali
5 papers
Ayalew Tefferi
5 papers
Hassan Alkhateeb
5 papers
James Foran
5 papers
Kebede Begna
5 papers
Kristen McCullough
5 papers
Mithun Shah
5 papers
Mrinal Patnaik
5 papers
Naseema Gangat
5 papers
William Hogan
5 papers
Abhishek Mangaonkar
4 papers